OnApril 13, 2022, the U.S. Food and Drug Administration (FDA) announced that Adamis Pharmaceuticals is voluntarily recallingcertain lotsof Symjepi (epinephrine) Injection 0.15 mg (0.15 mg/0.3 mL) and 0.3 mg (0.3 mg/0.3 mL) Pre-Filled Single-Dose Syringes as a Class I Recall. This is due to concerns that clogs in needles can prevent dispensing of epinephrine.

Please note that not all lots are affected, so you may not be affected by this recall. Your health and safety are important to us. If you are currently taking Symjepi (epinephrine) Injection, please contact your health care provider to talk about other treatments or medicines that may be appropriate.

For more information, please visitFDA.gov. You can also contact US WorldMeds at1-888-900-8796(TTY711), weekdays, 8 a.m. to 4 p.m., or byemail. The Horizon NJ Health Pharmacy Help Desk is available at1-800-682-9094x81016(TTY711), weekdays, 8 a.m. to 5 p.m., and Saturday, 8 a.m. to 4:30 p.m.